Paliperidone Palmitate CAS NO.199739-10-1

Send Inquiry
Paliperidone Palmitate CAS NO.199739-10-1
Details
Heterocyclic compounds
Category
Paliperidone APIs
Share to
Description

Paliperidone Palmitate Basic information

Product Name:

Paliperidone Palmitate

Synonyms:

(9RS)-3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl)et hyl)-2-Methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyriMi din-9-yl hexadecanoate;Hexadecanoic acid 3-[2-[4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]-ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester;Paliperidone Palmitate;Paliperidone Palmitate [USAN];Invega Sustenna;RO 92670;9-Hydroxyrisperidone palmitate;Hexadecanoic acid 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester

CAS:

199739-10-1

MF:

C39H57FN4O4

MW:

664.89

EINECS:

225-799-5

 

Paliperidone Palmitate Chemical Properties

Melting point 110-115°C
Boiling point 736.3±70.0 °C(Predicted)
density 1.19
storage temp. Sealed in dry,Store in freezer, under -20°C
solubility Chloroform (Slightly), Ethyl Acetate (Slightly, Heated, Sonicated), Methanol (Slightly)
form Solid
pka 8.07±0.10(Predicted)
color Off-White to Light Beige

 

Paliperidone Palmitate Usage And Synthesis

Description Paliperidone palmitate is an atypical long acting antipsychotics,which can fast onset in acute phase and continuously improve the symptoms in maintenance phase. It has the solid efficacy and convenient ad[1]ministration,which offer a new option for schizophrenia treatment and will help patients to adhere the treatment and prevent relapse. As the sole long acting antipsychotics with monthly injection,it was approved by CFDA in 2011 and indicated for the acute and maintenance treatment of schizophrenia.
Uses Paliperidone Palmitate is a long-acting injectable atypical antipsychotic used in the treatment of schizophrenia.

Papperidone palmitate, also known as palmitate, is a long-acting injection of the second-generation antipsychotic, which is mainly used to treat schizophrenia. The active ingredient is paliperidone. Paliperidone palmitate is very low in water solubility. Make paliperidone palmitate into fine particles through nanocrystal wet grinding, improve the water solubility, form a water suspension preparation suitable for intramuscular injection, and increase the absorption rate and bioavailability of the drug.

Hot Tags: paliperidone palmitate cas no.199739-10-1, China, manufacturers, suppliers, factory, custom, wholesale

Send Inquiry